Companies in the market could gain growth opportunities from pharmaceutical companies that are increasingly outsourcing their non-core activities and processes to solutions providers as a way of revising business strategies
As per Transparency Market Research (TMR), outsourcing noncore business activities will allow pharma companies to focus on their core competencies. Besides this, life sciences BPO services also enable companies to optimally utilize their available resources.
Developed countries have currently emerged as major contributors to the global life sciences BPO market. The technological advancements witnessed in these countries have helped the pharmaceutical outsourcing to significantly evolve in the last few years.
TMR pegs the global life sciences market to reach US$286.3 bn by the end of 2023. The market was valued at US$127.4 bn in 2014.
Obtain Report Details @ www.transparencymarketresearch.com…s-bpo-market.html
North America, Asia Pacific, Europe, and Rest of the World constitute the key regional segments of the global life sciences BPO market. Among these regions, North America emerged dominant in the market with a share of 38.6% in 2014.
The North America life sciences BPO market stood at US$49.1 bn in 2014. Rising at a CAGR of 6.2%, the market is expected to reach US$88.8 bn by the end of 2023.
Europe, on the other hand, has emerged as the second largest market for life sciences BPO in 2014. The rising demand for biosimilar drugs is expected to boost the market for life sciences BPO in the region.
However, TMR expects Asia Pacific to demonstrate the highest CAGR of 14.6% between 2015 and 2023. The high prices of raw materials, increasing pricing pressure, and the need for reducing cost have compelled various multinational pharmaceutical companies to outsource some of their business activities to developing nations.
Make an Enquiry @ www.transparencymarketresearch.com…S&rep_id=1782
Based on services, the life sciences BPO market can be segmented into CMO, CRO, and contract sales and marketing organizations (CSO). Of these, CMOs held the lion’s share in the market in 2014.
The increasing demand for generic products across developing markets and year-on-year rise in R&D investments by leading companies have been fuelling demand for services from CMOs for the past few years. TMR forecasts the CMO segment to exhibit a CAGR of 7.3% from 2015 and 2023.
Some of the leading companies operating in the global life sciences BPO market include Accenture plc, Boehringer Ingelheim GmbH, Anthelio Healthcare Solutions, Cognizant Technology Solutions, Catalent, Inc., PAREXEL International Corporation, International Business Machines Corporation, and others
Category: Market Research Publishers and RetailersCompany profile: TMR provides a range of marketing and business research solutions designed for your specific needs. From off-the-shelf syndicated business And market research to made-to-order custom research, we serve our clients to fulfill their immediate as well as ongoing research requirements. We specialize in the following areas: Syndicated Research Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverage ...
For more information:Make an Inquiry about this report HERE!